Compare Anza Therapeutics vs Bellicum Pharmaceuticals
Customers evaluate the quality of Anza Therapeutics's products using the following success metrics.
Overview
Anza Therapeutics is based in United States
Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.
Bellicum Pharmaceuticals is 20 yrs old and is based in United States.
Bellicum Pharmaceuticals is developing stem cell transplant, TCR, and CAR T cell therapies. Its product candidates incorporate molecular switches designed to allow activation or elimination of therapeutic cells once inside the body.
Demo Video
Leadership
David Cook (President)
Kevin Slawin (Founder)
Funding
Investors
Sofinnova Partners and Kleiner Perkins Caufield & Byers
Paycheck Protection Program, JLabs
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Anza Therapeutics has not claimed their profile.
Work for Anza Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Anza Therapeutics?
Claim your profile now.
Information not available because Bellicum Pharmaceuticals has not claimed their profile.
Work for Bellicum Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Bellicum Pharmaceuticals?
Claim your profile now.